Synergistically Therapeutic Effects of VEGF165 and Angiopoietin-1 on Ischemic Rat Myocardium
Document Type
Article
Publication Date
4-24-2007
Description
Purpose: The aim of this study was to determine whether the combination of 2 angiogenic growth factor, vascular endothelial growth factor 165(VEGF165) and angiopoietin-1 (Ang1), could increase angiogenesis and cardiomyocyte(CM) proliferation in an infarcted myocardium. Methods: Myocardial ischemia was induced in rats by ligation of the left anterior descending (LAD) coronary artery. Replication-deficient adenoviruses encoding VEGF165 (Ad-VEGF165), Ang1 (Ad-Ang1) or enhanced green fluorescence protein (Ad-EGFP) was injected into the ischemic myocardium immediately. Bromodexyuridine (BrdU) was administered intraperitoneally 1 week after ligation. One week later, the hearts were harvested and sectioned for hematoxylin-eosin (HE) and immunohistochemistry to evaluate densities of capillary, arteriole and double labelled BrdU(+) CM. M-mode echocardiography was used to evaluate the cardiac function. Results: Ang1 significantly increased collateral vessel formation. Both VEGF165 and Ang1 significantly increased densities of capillary and arteriole, as well as the number of double labelled BrdU(+) CM, and improved cardiac function. Conclusion: Our results suggest that the combination of VEGF165 and Ang1 can increase both myocardial angiogenesis and CM proliferation following myocardial ischemia in rats, leading to improved cardiac function.
Citation Information
Liu, Xiang; Chen, Yijiang; Zhang, Fumin; Chen, Lizhen; Ha, Tuanzhu; Gao, Xiang; and Li, Chuanfu. 2007. Synergistically Therapeutic Effects of VEGF165 and Angiopoietin-1 on Ischemic Rat Myocardium. Scandinavian Cardiovascular Journal. Vol.41(2). 95-101. https://doi.org/10.1080/14017430701197593 PMID: 17454834 ISSN: 1401-7431